Alzpath said Monday that it has licensed a proprietary Alzheimer's disease biomarker to Siemens Healthineers for use in an assay for the brain disorder. The deal covers an antibody to ...

Jefferies analyst Tycho Peterson cited the large addressable market for the company's PreTRM blood test for assessing pregnant women's risk of preterm birth.

Should the €6.3 million effort prove successful, it could lead to the adoption of Volition's assay for routine clinical use across France.

NEW YORK — Alzpath said on Monday that it has licensed a proprietary Alzheimer's disease biomarker to Siemens Healthineers for use in an assay for the brain disorder.

CBO's recent score tallied temporary PAMA delay as a cost rather than a savings, potentially making future delays less likely ...

With the approval, the company's automated clinical mass spec system, the Cobas I 601 analyzer, features an in vitro diagnostic menu of 39 tests.

The company intends to use the funding to advance its AI-powered microscopy system for infectious disease analysis.

Uniogen's progress toward clinical commercialization aligns with larger internal goals of bringing cancer diagnostics to market, with a specific focus on women's health.

The study will evaluate the performance of Syantra's blood-based Onco-ID Breast molecular assay for screening women at elevated risk of breast cancer.

The digital immunoassay platform is designed to detect and quantify proteins at the single-molecule level in blood, serum, or plasma. The platform includes the Simoa HD-X Immunoassay Analyzer, which ...